Neurofibromatosis Cell Panel
30-5500K ™
The NTAP (Neurofibromatosis Therapeutic Acceleration Program) cell panel consists of 6 hTERT-immortalized wild type NF1 and neurofibroma-derived cell lines harboring NF1 mutations. These are highly genotypically characterized tools for research in drug discovery and therapeutics. With generous support from NTAP, the purchasers of these cells are eligible to receive up to 100% reimbursement from NTAP.
For‑profit customers intending to use this product for non-commercial screening must include the one-time “ATCC Screening Fee” (ATCC® ACS‑2103F) with their first purchase of this product.